Akbar Farjadfar

Akbar Farjadfar

Auto-generated profile, based on publicly available information

Akbar Farjadfar

Department of Biotechnology, Fasa University of Medical Sciences, Fasa, Iran

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in Acta Oncologica
Verified
Journal Article
Closed access
AFAkbar Farjadfar
Akbar Farjadfar
ZMZahra Mojtahedi
Zahra Mojtahedi
MGMohammad Ali Ghayumi
Mohammad Ali Ghayumi
NENasrolla Erfani
Nasrolla Erfani
MHMohammad Reza Haghshenas
Mohammad Reza Haghshenas
AGAbbas Ghaderi
Abbas Ghaderi
Interleukin-18 (IL-18) is a multifunctional cytokine that augments IFN-gamma production and affects tumor immune response. In the present case-control study, we tested whether IL-18 promoter polymorphism contributes to lung cancer susceptibility in Iranian patients. The study groups were 73 patients with lung cancer, including 53 with squamous carcinoma (SC) and 20 with small cell lung carcinoma (SCLC), and 97 healthy regional aged-matched individuals. The frequency of IL-18 promoter single nucleotide polymorphisms (SNPs) at positions -656 (G/T), -607 (C/A), and -137 (G/C) was determined by polymerase chain reaction analyses. There were significant differences in the IL-18 -607 allele and genotype distributions between the 73 lung cancer patients and controls. A significantly higher A allele frequency at position -607, which is associated with lower IL-18 production, was observed in lung cancer patients (48.6% vs. 35%; OR = 1.75; 95% CI 1.13-2.72). Also, patients with the -607 CA and the AA genotypes had a 2.60-fold (95% CI 1.26-5.36) and 3.15-fold (95% CI 1.16-8.55) increase in risk of lung cancer. Subdivision of the patients according to histological type revealed that SC was significantly associated with IL-18 -607 SNPs. Although the percentages of -607 alleles and genotypes in SCLC patients were similar to the results in SC patients, the differences compared to control individuals did not reach statistical significance. Analysis with Arlequin software identified eight haplotypes from three SNPs analyzed here. The distributions of IL-18 gene haplotypes were not significantly different between patients and controls after Bonferroni correction. This is the first report to investigate the association between IL-18 polymorphism and lung cancer. Our results suggest that IL-18 polymorphism contributes to the lung cancer risk, particularly among SC patients. Further studies with larger numbers of patients are required to determine the possible association between IL-18 polymorphisms and different histological types of lung cancer.

6 October 2016 in Parasite Immunology
Verified
Journal Article
Closed access
PDF file
NMN. Mortazavidehkordi
N. Mortazavidehkordi
AFA. Farjadfar
A. Farjadfar
HKH. Khanahmad
H. Khanahmad
ZNZ. Ghayour Najafabadi
Z. Ghayour Najafabadi
NHN. Hashemi
N. Hashemi
SHseyed hossein Hejazi
seyed hossein Hejazi

1 October 2017
Verified
Journal Article
Open access
PDF file
AHAhmad Hosseini
Ahmad Hosseini
HEHajar Estiri
Hajar Estiri
HNHaleh Akhavan Niaki
Haleh Akhavan Niaki
AAAkram Alizadeh
Akram Alizadeh
BZBaharak Abdolhossein Zadeh
Baharak Abdolhossein Zadeh
AFAli Fallah
Ali Fallah
These results showed that gene therapy using anti-inflammatory cytokines can be a promising approach against multiple sclerosis (MS). In addition, considering the immunomodulatory potential of WJSCs, an approach using a combination of WJSCs and gene therapy will enhance the treatment efficacy.

1 March 2010
Verified
Journal Article
Closed access
HEHasan Ebrahimi
Hasan Ebrahimi
MSMasoud Soleimani
Masoud Soleimani
MAMohammad Kazemi Arababadi
Mohammad Kazemi Arababadi
NANaser Ahmadbeigi
Naser Ahmadbeigi
GHGholamhossein Hassanshahi
Gholamhossein Hassanshahi
DKDerek Kennedy
Derek Kennedy